DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-799 Cr | ₹-799 Cr | ₹-797 Cr | ₹-532 Cr | ₹-35 Cr |
What is the latest Cash Flow from Financing Activities ratio of DIVIS LABORATORIES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2025 | ₹-799 Cr |
Mar2024 | ₹-799 Cr |
Mar2023 | ₹-797 Cr |
Mar2022 | ₹-532 Cr |
Mar2021 | ₹-35 Cr |
How is Cash Flow from Financing Activities of DIVIS LABORATORIES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹-799 Cr | Negative | |
Mar2024 | ₹-799 Cr | Negative | |
Mar2023 | ₹-797 Cr | Negative | |
Mar2022 | ₹-532 Cr | Negative | |
Mar2021 | ₹-35 Cr | - |
Compare Cash Flow from Financing Activities of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹162,864.3 Cr | -3.7% | -6.9% | 30.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,478.0 Cr | -5.9% | -2.8% | -5.3% | Stock Analytics | |
CIPLA | ₹120,121.0 Cr | -3.9% | -0.8% | -0.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,327.0 Cr | -3.8% | 7.1% | 12% | Stock Analytics | |
MANKIND PHARMA | ₹105,380.0 Cr | 1.6% | 8.4% | 31.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,907.8 Cr | -6% | -7.3% | -12% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -3.7% |
-6.9% |
30.1% |
SENSEX | -1.2% |
-3.5% |
-0.5% |
You may also like the below Video Courses